Diasio RB - Search Results

1

Clinical pharmacology of 5-fluorouracil.

Diasio RB, Harris BE. Diasio RB, et al. Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002. Clin Pharmacokinet. 1989. PMID: 2656050 Review.

2

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors.

Adjei AA, Reid JM, Diasio RB, Sloan JA, Smith DA, Rubin J, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton P, Ames MM, Erlichman C. Adjei AA, et al. Among authors: diasio rb. J Clin Oncol. 2002 Mar 15;20(6):1683-91. doi: 10.1200/JCO.2002.20.6.1683. J Clin Oncol. 2002. PMID: 11896120 Clinical Trial.

3

Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.

Schilsky RL, Hohneker J, Ratain MJ, Janisch L, Smetzer L, Lucas VS, Khor SP, Diasio R, Von Hoff DD, Burris HA 3rd. Schilsky RL, et al. J Clin Oncol. 1998 Apr;16(4):1450-7. doi: 10.1200/JCO.1998.16.4.1450. J Clin Oncol. 1998. PMID: 9552051 Clinical Trial.

4

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB. Heggie GD, et al. Among authors: diasio rb. Cancer Res. 1987 Apr 15;47(8):2203-6. Cancer Res. 1987. PMID: 3829006

5

Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.

Sommadossi JP, Gewirtz DA, Cross DS, Goldman ID, Cano JP, Diasio RB. Sommadossi JP, et al. Among authors: diasio rb. Cancer Res. 1985 Jan;45(1):116-21. Cancer Res. 1985. PMID: 3965128

6

Alteration of the secondary structure of newly synthesized DNA from murine bone marrow cells by 5-fluorouracil.

Schuetz JD, Collins JM, Wallace HJ, Diasio RB. Schuetz JD, et al. Among authors: diasio rb. Cancer Res. 1986 Jan;46(1):119-23. Cancer Res. 1986. PMID: 3940183

7

Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.

Diasio RB, Schuetz JD, Wallace HJ, Sommadossi JP. Diasio RB, et al. Cancer Res. 1985 Oct;45(10):4900-3. Cancer Res. 1985. PMID: 3928143

8

A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patients.

Coustère C, Mentré F, Sommadossi JP, Diasio RB, Steimer JL. Coustère C, et al. Among authors: diasio rb. Cancer Chemother Pharmacol. 1991;28(2):123-9. doi: 10.1007/BF00689701. Cancer Chemother Pharmacol. 1991. PMID: 2060083

9

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.

Harris BE, Song R, Soong SJ, Diasio RB. Harris BE, et al. Among authors: diasio rb. Cancer Res. 1990 Jan 1;50(1):197-201. Cancer Res. 1990. PMID: 2293556

10

Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora.

Harris BE, Manning BW, Federle TW, Diasio RB. Harris BE, et al. Among authors: diasio rb. Antimicrob Agents Chemother. 1986 Jan;29(1):44-8. doi: 10.1128/aac.29.1.44. Antimicrob Agents Chemother. 1986. PMID: 3729334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results